PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infus… Read more
PW MEDTECH GROUP DL-0001 (PWE) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, PW MEDTECH GROUP DL-0001 (PWE) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
PW MEDTECH GROUP DL-0001 - Net Assets Trend (None–None)
This chart illustrates how PW MEDTECH GROUP DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PW MEDTECH GROUP DL-0001 (None–None)
The table below shows the annual net assets of PW MEDTECH GROUP DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to PW MEDTECH GROUP DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
PW MEDTECH GROUP DL-0001 Competitors by Market Cap
The table below lists competitors of PW MEDTECH GROUP DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OS Therapies Incorporated
NYSE MKT:OSTX
|
$40.59 Million |
|
Effecten-Spiegel AG
STU:EFS
|
$40.60 Million |
|
Zimmite Taiwan Ltd
TWO:8435
|
$40.61 Million |
|
Allcargo Logistics Limited
NSE:ALLCARGO
|
$40.62 Million |
|
AIRTIF.INTEL.STR. EO-09
F:IRG
|
$40.54 Million |
|
Hester Biosciences Limited
NSE:HESTERBIO
|
$40.52 Million |
|
RESERVOIR CAPITAL
F:R0C
|
$40.52 Million |
|
DLP Resources Inc
OTCQB:DLPRF
|
$40.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PW MEDTECH GROUP DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares PW MEDTECH GROUP DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently PW MEDTECH GROUP DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares PW MEDTECH GROUP DL-0001's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PW MEDTECH GROUP DL-0001 (PWE) | €- | N/A | N/A | $40.56 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $213.74 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $475.06 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $32.92 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $217.64 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $658.78 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $783.58 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.63 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.27 Billion |